3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Zhang et al. Sci China Chem
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
poured onto the solid ice and the crude product was separated
out gradually. The crude product was filtered to get the solid
product and dried before the next step [18].
nitric acid solutions was contacted with a 1 mL organic phase
containing 1.0 mM Et-Et-DAPhen, But-But-DAPhen, Hex-
Hex-DAPhen and Oct-Oct-DAPhen in 1-(trifluoromethyl)-
3-nitrobenzene, respectively. A phase ratio of 2:1 aqueous:
organic phase was used here to reduce the usage of organic
diluents and achieve a higher extraction capacity. 1-(Tri-
fluoromethyl)-3-nitrobenzene was used as a diluent in view
of its good dissolving capacity towards DAPhen ligands,
strong hydrophobicity, and suitable density. Prior to extrac-
tion, the organic phase was pre-equilibrated with the aqueous
phase of the same composition as the extraction experiment
except being void of uranium. The kinetics data indicated
that 20 min is enough to reach extraction equilibrium for all
the four ligands. Thus all the extraction experiments were
carried out for 30 min with the aid of a vortex shaker. After
2 min of centrifugation at 6000 r/min, the concentration of
2.1.2 N,N′-Diethyl-N,N′-diethyl-2,9-diamide-1,10-phenan-
throline (Et-Et-DAPhen)
2,9-Diacyl chloride-1,10-phenanthroline was synthesized by
adding 2.9-dicarboxylic acid-1,10-phenanthroline (2.86 g,
10.68 mmol) into the thionyl chloride (70 mL) and refluxing
under 85 °C for 3 h. After removal of the thionyl chloride by
reduced pressure distillation, dichloromethane (70 mL) was
added as the solvent, and diethylamine (1.72 g, 23.51 mmol)
and triethylamine (4.76 g, 47.00 mmol) were added slowly
into the mixture. After 3 h refluxing under nitrogen atmo-
sphere, the solvent was removed by reduced pressure dis-
tillation. The residue was purified with silica gel column
chromatography (eluent: CH3OH/CHCl3=1/50), yielding
white powders of ligand a (3.16 g, 78.08%). ESI-MS: m/z (M
2+
UO2 in the aqueous phase was determined by inductively
coupled plasma optical emission spectrometer (ICP-OES,
Horiba JY2000-2, Japan). For ICP-OES measurement (the
detection limit is below 0.01 ppm), the supernatant was di-
luted 25–100 times to make sure that the UO22+ concentration
in the dilution is 1–5 μg/mL. The distribution ratio (D) was
calculated as follows:
1
+H)+ 379.2. H NMR (500 MHz, CDCl3): δ=8.64 (d, J=
8.0 Hz, 2H), 8.12 (s, 2H), 7.95 (d, J=8.0 Hz, 2H), 3.55 (q, J=
8.0 Hz, 4H), 3.41 (q, J=8.0 Hz, 4H), 1.22 (t, J=8.0 Hz, 12H).
N,N′-Dibutyl-N,N′-dibutyl-2,9-diamide-1,10-phenanthro-
line (But-But-DAPhen), N,N′-dihexyl-N,N′-dihexyl-2,9-dia-
mide-1,10-phenanthroline (Hex-Hex-DAPhen) and N,N′-
dioctyl-N,N′-dioctyl-2,9-diamide-1,10-phenanthro-line
(Oct-Oct-DAPhen), were synthesized following the same
procedure as that used for N,N′-diethyl-N,N′-diethyl-2,9-
diamide-1,10-phenanthroline except that dibutylamine, di-
hexylamine and diotcylamine instead of diethylamine were
used, respectively. All the ligands were characterized by ESI-
MS and NMR, as shown as follows: N,N′-Dibutyl-N,N′-di-
butyl-2,9-diamide-1,10-phenanthroline (yield 66.1%), ESI-
MS: m/z (M+H)+ 491.4. 1H NMR (500 MHz, CDCl3): δ=8.63
(d, J=8.3 Hz, 2H), 8.11 (s, 2H), 7.92 (d, J=8.3 Hz, 2H), 3.51
(q, J=7.5 Hz, 4H), 3.40 (q, J=7.5 Hz, 4H), 1.70–1.64 (m,
8H), 1.44–1.39 (m, 4H), 0.99–0.96 (m, 10H), 1.55 (t, J=
7.5 Hz, 6H). N,N′-Dihexyl-N,N′-dihexyl-2,9-diamide-1,10-
phenanthroline (yield 37.8%), ESI-MS: m/z (M+H)+ 603.5.
(Ci Cf)
2Cf
D =
,
(1)
where Ci and Cf represent the initial and final concentrations
of U(VI) in the aqueous phase, respectively; 2 designates the
volume ratio of organic phase and aqueous phase during the
extraction. Above equations for calculation of the D value
made a convenience that only the aqueous phase was mea-
sured. All values were measured in duplicate with un-
certainty within 5%.
2+
For UO2 stripping, the organic phase loaded with UO22+
was contacted with an equal volume of ultrapure water
during 30 min at room temperature with the aid of a vortex
shaker. The resulting mixture was centrifuged at 6000 r/min
for 2 min and the organic phase was separated completely
2+
from the aqueous phase. The concentration of UO2 in the
1H NMR (500 MHz, CDCl3): δ=8.63 (d, J=8.0 Hz, 2H), 8.11
(s, 2H), 7.92 (d, J=8.0 Hz, 2H), 3.51–3.44 (m, 8H), 1.68–
1.62 (m, 8H), 1.35 (m, 12H), 0.91 (m, 18H), 0.49 (m, 4H). N,
N′-Dioctyl-N,N′-dioctyl-2,9-diamide-1,10-phenanthroline
(yield 22.2%), ESI-MS: m/z (M+H)+ 735.2. 1H NMR
(500 MHz, CDCl3): δ=8.63 (d, J=8.0 Hz, 2H), 8.12 (s, 2H),
7.93 (d, J=8.0 Hz, 2H), 3.50 (q, J=8.0 Hz, 8H), 1.61 (m, 8H),
1.37–1.30 (m, 20H), 0.93–0.88 (m, 26H), 0.67 (m, 6H).
aqueous phase was determined by the ICP-OES method.
2.3 UV-Vis titration
The absorption spectroscopy was measured by a HITACHI
2+
U-3600 (Japan). Stoke solutions of 0.002 M UO2 in acet-
onitrile were prepared by dissolving the UO2(NO3)3·6H2O
solid into HPLC grade acetonitrile; The concentration of li-
gands in acetonitrile was 2.0×10−5 M. And 0.01 M tetra-
ethylammonium nitrate (Et4NNO3) was added into the ligand
solutions to control the ionic strength. Each 10 μL of the
2.2 Solvent extraction experiments
2+
2+
A stock solution of UO2 was prepared by dissolving the
UO2 solutions were titrated into 5 mL of the ligand solu-
UO2(NO3)3·6H2O solid with ultrapure water in a volumetric
flask. A 2 mL aqueous phase consisting of 0.5 mM UO22+ in
tion. After mixing for 15 min, the absorption spectroscopy of
the solution was measured with a 1.0 cm quartz cell. The